Use of metalonin for cardiovascular disease/Myocardial ischemia-reperfusion injury and metatonin [9]

dc.authorscopusid55665568500
dc.contributor.authorVardar S.A.
dc.date.accessioned2024-06-12T10:28:56Z
dc.date.available2024-06-12T10:28:56Z
dc.date.issued2006
dc.description.abstract[No abstract available]en_US
dc.identifier.issn1302-8723
dc.identifier.issue3en_US
dc.identifier.pmid16943125en_US
dc.identifier.scopus2-s2.0-33748710839en_US
dc.identifier.scopusqualityN/Aen_US
dc.identifier.startpage293en_US
dc.identifier.urihttps://hdl.handle.net/20.500.14551/17494
dc.identifier.volume6en_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isotren_US
dc.relation.ispartofAnadolu Kardiyoloji Dergisien_US
dc.relation.publicationcategoryDiğeren_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectBeta Adrenergic Receptor Blocking Agent; Calcium Antagonist; Captopril Plus Hydrochlorothiazide; Melatonin; Scavenger; Alzheimer Disease; Angina Pectoris; Blood Pressure; Cardiovascular Disease; Circadian Rhythm; Colon Cancer; Coronary Artery; Diastolic Blood Pressure; Heart Infarction Prevention; Heart Muscle Ischemia; Human; Hypertension; Jet Lag; Letter; Myocardial Hibernation; Prostate Cancer; Protein Synthesis; Reperfusion Injury; Stunned Heart Muscle; Syndrome X; Systolic Blood Pressure; Heart Muscle Ischemia; Note; Reperfusion Injury; Free Radical Scavengers; Humans; Melatonin; Myocardial Ischemia; Myocardial Reperfusion Injuryen_US
dc.titleUse of metalonin for cardiovascular disease/Myocardial ischemia-reperfusion injury and metatonin [9]en_US
dc.title.alternativeMetaninin kalp ve dolaşm sistemi hastaliklarinda kullanimi/Miyokardiyal iskemi-reperfüzyon hasari ve melatoninen_US
dc.typeLetteren_US

Dosyalar